Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

Share on Pinterest LeoPatrizi/Getty Images Semaglutide is the active ingredient in Wegovy, Ozempic, and Rybelsus. Currently, only Wegovy is approved for weight loss in the United States.

Image Credit: Caroline Ruda/Shutterstock.com In comparison to insulin treatment, semaglutide was found to significantly reduce the risk of first-time Alzheimer's disease (AD) diagnosis.

placebo. Adults with obesity lost about 21% of their body weight at 72 weeks with semaglutide 7.2 mg. Image: Adobe Stock In the trial product estimand, adults receiving semaglutide 7.2 mg had a 20 ...